← Open Payments lookup

KATHRYN CAMPION: Open Payments

NPI 1659992386 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$605 in 15 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $134 · 2025 $605

Food & beverage: $605
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$236
Janssen Biotech, Inc.2$155
Bayer Healthcare Pharmaceuticals Inc.2$55
Gilead Sciences, Inc.2$44
TerSera Therapeutics LLC1$28
Genmab U.S., Inc.1$26
E.R. Squibb & Sons, L.L.C.1$23
Janssen Scientific Affairs, LLC1$19
Daiichi Sankyo Inc.1$19

Products named: DARZALEX, Stivarga, Xermelo, Epkinly, TECVAYLI, OPDIVO.

Industry payments across MD — which companies pay providers there.